Overview
Eukaryotic transcriptome sequencing, also known as RNA-seq, is a powerful technique that profiles the complete set of RNA transcripts in a cell or tissue. This includes messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), and non-coding RNA (ncRNA), particularly long non-coding RNA (lncRNA). By sequencing the transcriptome, researchers and clinicians can gain insights into gene expression levels, alternative splicing events, and post-transcriptional modifications. Reference-based analysis aligns the sequenced reads to a reference genome or transcriptome, enabling the identification of known transcripts, quantification of gene expression, and discovery of novel transcripts or splicing variants. lncRNAs are a class of ncRNA molecules longer than 200 nucleotides that do not encode proteins but play critical roles in gene regulation, chromatin remodeling, and epigenetic modification. Dysregulation of lncRNAs has been implicated in various diseases, including cancer, neurological disorders, and cardiovascular conditions. DNA Labs India offers a comprehensive transcriptome sequencing service that includes lncRNA analysis at an affordable cost of INR 48,000. Our state-of-the-art sequencing platforms and advanced bioinformatics pipelines ensure high accuracy and reliability. The service includes free home sample collection across major cities in India, making it convenient for patients and researchers. The detailed report provides gene expression profiles, differential expression analysis, and lncRNA annotations, which can be used for research and clinical applications.
To be completed — reclassified from Tests on 2026-11-13.
The purpose of eukaryotic transcriptome sequencing with reference-based analysis is to comprehensively characterize the RNA landscape of a sample. This includes identifying differentially expressed genes, detecting alternative splicing events, and quantifying lncRNA expression. It is used in research to understand disease mechanisms, discover biomarkers, and identify therapeutic targets. In clinical settings, it can aid in the diagnosis of genetic disorders, particularly those involving splicing defects or aberrant gene expression.
Sample requirements
What to send us
Deliverables & turnaround
What you receive
Turnaround: Results are typically available within 8 weeks after the sample reaches the laboratory.
Pricing
Transparent pricing
| Option | Turnaround | Price (INR) | Unit |
|---|---|---|---|
| Standard | Results are typically available within 8... | ₹48,000 | per sample |
Limitations & precautions
What this service cannot do
Questions customers ask
Frequently asked questions
What is the cost of the test?
The cost is INR 48,000, which includes sequencing, analysis, and a detailed report.
What sample is required?
The sample type is extracted RNA, typically from blood or tissue.
How long does it take to get results?
Results are available in approximately 8 weeks.
Is home sample collection available?
Yes, we offer free home sample collection for online bookings across major cities in India.
What is lncRNA?
Long non-coding RNA (lncRNA) are RNA molecules longer than 200 nucleotides that do not code for proteins but regulate gene expression.
Can this test diagnose cancer?
It is not a diagnostic test for cancer but can provide information on gene expression changes that may be associated with cancer.
What is reference-based analysis?
It is a bioinformatics method that aligns sequenced RNA reads to a reference genome to identify and quantify transcripts.
Do I need to fast before the test?
No, fasting is not required.
What is the turnaround time?
The turnaround time is 8 weeks.
Are there any risks?
The risks are minimal, similar to a routine blood draw or biopsy.
Can this test be used for research?
Yes, it is widely used in research for gene expression profiling and biomarker discovery.
Is the test NABL accredited?
Yes, DNA Labs India is NABL accredited and ISO certified.
Continue here
Related services
Enquiry
Request a quote or ask a question
Editorial accountability